Hemostasis in elderly patients with human immunodeficiency virus (HIV) infection-Cross-sectional study

scientific article published on 12 February 2020

Hemostasis in elderly patients with human immunodeficiency virus (HIV) infection-Cross-sectional study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PONE.0227763
P932PMC publication ID7015422
P698PubMed publication ID32049963

P50authorMarilza Campos-de-MagalhãesQ76322027
Soniza V Alves-LeonQ88297048
Isabelle Vasconcellos de SouzaQ89678944
P2093author name stringAdilson José de Almeida
Fernando Raphael de Almeida Ferry
Ana Carolina de Brito Lyra
Juan Camilo Sánchez-Arcila
Luiz Felipe Boufleur Long
P2860cites workAntiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic reviewQ22242702
HIV and Menopause: A Systematic Review of the Effects of HIV Infection on Age at Menopause and the Effects of Menopause on Response to Antiretroviral TherapyQ26852180
Understanding frailty, aging, and inflammation in HIV infectionQ27021143
Markers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patientsQ27024262
Inflammatory and coagulation biomarkers and mortality in patients with HIV infectionQ28473903
Aging hemostasis: changes to laboratory markers of hemostasis as we age - a narrative reviewQ38237513
A review of the value of D-dimer testing for prediction of recurrent venous thromboembolism with increasing age.Q38237514
Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapyQ38603237
Trends in life expectancy of HIV-positive adults on antiretroviral therapy across the globe: comparisons with general populationQ38851681
Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers.Q40215452
Coagulation imbalance and neurocognitive functioning in older HIV-positive adults on suppressive antiretroviral therapyQ40367422
Biomarkers and Clinical Indices of Aging with HIV.Q40440334
Therapeutic advances: protease inhibitors for the treatment of HIV-1 infectionQ40898009
Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective studyQ41067770
Elevated ischemic stroke risk among women living with HIV infectionQ41996527
Cerebrovascular events in HIV-infected patients: an analysis of a cohort of 3203 HIV+ patients during the times of cART.Q42197898
HIV is associated with thrombophilia and high D-dimer in children and adolescents.Q43157187
The hemostatic balance in HIV-infected patients with and without antiretroviral therapy: partial restoration with antiretroviral therapyQ43237794
Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study.Q44492237
Correlation of CD4 count with platelet count, prothrombin time and activated partial thromboplastin time among HIV patients in Benin City, NigeriaQ45227470
Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infectionQ45729086
Viral load and disease progression as responsible for endothelial activation and/or injury in human immunodeficiency virus-1-infected patients.Q45729419
Endothelial dysfunction, increased inflammation, and activated coagulation in HIV-infected patients improve after initiation of highly active antiretroviral therapy.Q46431385
Anti-viral activity of human antithrombin III.Q46597118
HIV and the menopause: A review.Q47292815
Geriatric-HIV medicine: A science in its infancyQ48352423
Ageing and inflammation in patients with HIV infection.Q30244296
Hemostasis factors and agingQ33299066
Effects of first-line anti-retroviral therapy on blood coagulation parameters of HIV-infected patients attending a tertiary hospital at Abuja, NigeriaQ33434893
Cytomegalovirus-specific T cells persist at very high levels during long-term antiretroviral treatment of HIV diseaseQ33528999
HIV infection and aging independently affect brain function as measured by functional magnetic resonance imagingQ33583519
Is HIV a model of accelerated or accentuated aging?Q33792651
Correlates of D-dimer in older personsQ33825375
Serpin induced antiviral activity of prostaglandin synthetase-2 against HIV-1 replicationQ33886860
Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammationQ34288534
Association between older age and adverse outcomes on antiretroviral therapy: a cohort analysis of programme data from nine countriesQ34332446
Chronic HIV disease and activation of the coagulation systemQ34342368
In vivo anti-HIV activity of the heparin-activated serine protease inhibitor antithrombin III encapsulated in lymph-targeting immunoliposomesQ34469655
Antithrombin: a new look at the actions of a serine protease inhibitorQ35004303
Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulationQ35021902
HIV infection in the elderlyQ35086332
Association of antiretroviral therapy with fibrinogen levels in HIV-infectionQ35166181
HIV status and the risk of ischemic stroke among men.Q35611619
Management of protease inhibitor-associated hyperlipidemiaQ35631233
HIV infection is associated with decreased thrombin generationQ35845337
Elevated Biomarkers of Inflammation and Coagulation in Patients with HIV Are Associated with Higher Framingham and VACS Risk Index ScoresQ35862321
Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral TherapyQ36015621
Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosisQ36250909
Hemostasis and agingQ36543985
Association of Serum Sex Hormones with Hemostatic Factors in Women On and Off Hormone Therapy: The Multiethnic Study of AtherosclerosisQ36602044
Early immune senescence in HIV diseaseQ37084912
Study of Basic Coagulation Parameters among HIV Patients in Correlation to CD4 Counts and ART StatusQ37102595
Cytomegalovirus and human immunosenescenceQ37335339
Premature aging of T cells is associated with faster HIV-1 disease progressionQ37399302
Role of T-Cell Dysfunction, Inflammation, and Coagulation in Microvascular Disease in HIV.Q37556442
The hemostatic system through aging and menopause.Q37610388
Menopause and aging: changes in the immune system--a review.Q37784916
Human immunodeficiency virus and menopauseQ38093357
Biologic aging, frailty, and age-related disease in chronic HIV infectionQ38212714
Aging with HIV infection: a journey to the center of inflammAIDS, immunosenescence and neuroHIV.Q38226374
Cognitive impairment among older adults living with HIV/AIDS and frailty.Q51787081
Elevated fibrinogen causes thrombosis.Q52845746
Fibrinogen and Fibrin in Hemostasis and Thrombosis.Q54842287
Basic Coagulation Parameters among Human Immunodeficiency Virus-Infected Adults in Gondar, Northwest Ethiopia: A Comparative Cross-Sectional Study.Q55310223
Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIVQ56837870
D-dimer use for deep venous thrombosis exclusion in elderly patients: a comparative analysis of three different approaches to establish cut-off values for an assay with results expressed in D-dimer unitsQ56972703
Metabolic syndrome in human immunodeficiency virus-infected patientsQ59359662
Age-related changes in the hemostatic systemQ70668496
Fibrin Degeneration Product Concentrations (D-Dimers) in the Course of AgeingQ71846271
Age and functional correlations of markers of coagulation and inflammation in the elderly: functional implications of elevated crosslinked fibrin degradation products (D-dimers)Q72021999
Antithrombin III: associations with age, race, sex and cardiovascular disease risk factors. The Atherosclerosis Risk in Communities (ARIC) Study InvestigatorsQ72600744
Persistently elevated levels of von Willebrand factor antigen in HIV infection. Downregulation during highly active antiretroviral therapyQ74225980
Inflammatory/hemostatic biomarkers and cardiovascular risk: coming of age?Q80048925
Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health StudyQ80048927
Relationship between progression to AIDS and thrombophilic abnormalities in HIV infectionQ81199933
HIV in the elderly: an emergent challengeQ84058700
Coagulation factors and antithrombin levels in young and elderly subjects in Pakistani populationQ85389008
HIV and cardiovascular diseases risk: exploring the interplay between T-cell activation, coagulation, monocyte subsets, and lipid subclass alterationsQ91617762
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue2
P304page(s)e0227763
P577publication date2020-02-12
P1433published inPLOS OneQ564954
P1476titleHemostasis in elderly patients with human immunodeficiency virus (HIV) infection-Cross-sectional study
P478volume15

Reverse relations

Q90356617Correction: Hemostasis in elderly patients with human immunodeficiency virus (HIV) infection-Cross-sectional studycites workP2860

Search more.